BRUKER CORPORATION Impairment of Long-Lived Assets Held-for-use
BRUKER CORPORATION (BRKR) reported Impairment of Long-Lived Assets Held-for-use of $2.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2026-08-05
- BRUKER CORPORATION impairment of long-lived assets held-for-use for the quarter ending 2026-06-30 was $2.70M, a 125.00% increase year-over-year.
- BRUKER CORPORATION impairment of long-lived assets held-for-use for the quarter ending 2026-03-31 was $12.90M, a 1742.86% increase year-over-year.
- BRUKER CORPORATION impairment of long-lived assets held-for-use for the quarter ending 2025-12-31 was $2.00M.
- BRUKER CORPORATION impairment of long-lived assets held-for-use for the quarter ending 2025-09-30 was $10.90M, a 890.91% increase year-over-year.
- BRUKER CORPORATION impairment of long-lived assets held-for-use for fiscal 2025 was $14.80M, a 572.73% increase from fiscal 2024.
- BRUKER CORPORATION impairment of long-lived assets held-for-use for fiscal 2024 was $2.20M, a 61.40% decline from fiscal 2023.
- BRUKER CORPORATION impairment of long-lived assets held-for-use for fiscal 2023 was $5.70M, a 1800.00% increase from fiscal 2022.
- BRUKER CORPORATION impairment of long-lived assets held-for-use for fiscal 2022 was $300.00K.
| Period end | Impairment of Long-Lived Assets Held-for-use 3 month | Impairment of Long-Lived Assets Held-for-use 6 month | Impairment of Long-Lived Assets Held-for-use 9 month | Impairment of Long-Lived Assets Held-for-use 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.70M 10-Q · filed 2026-08-05 | $15.60M 10-Q · filed 2026-08-05 | $17.60M derived: sum of 3 quarters · filed 2026-08-05 | $28.50M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $12.90M 10-Q · filed 2026-05-07 | $14.90M derived: sum of 2 quarters · filed 2026-05-07 | $25.80M derived: sum of 3 quarters · filed 2026-05-07 | $27.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $12.90M derived: sum of 2 quarters · filed 2026-02-27 | $14.10M derived: sum of 3 quarters · filed 2026-08-05 | $14.80M 10-K · filed 2026-02-27 |
| 2025-09-30 | $10.90M 10-Q · filed 2025-11-05 | $12.10M derived: sum of 2 quarters · filed 2026-08-05 | $12.80M 10-Q · filed 2025-11-05 | $12.80M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.20M 10-Q · filed 2026-08-05 | $1.90M 10-Q · filed 2026-08-05 | $1.90M derived: sum of 3 quarters · filed 2026-08-05 | $3.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $700.00K 10-Q · filed 2026-05-07 | $700.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.80M derived: sum of 3 quarters · filed 2026-05-07 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.10M derived: sum of 2 quarters · filed 2026-02-27 | $2.20M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $1.10M 10-Q · filed 2025-11-05 | $2.20M 10-Q · filed 2025-11-05 | ||
| 2023-12-31 | $5.70M 10-K · filed 2026-02-27 | |||
| 2022-12-31 | $300.00K 10-K · filed 2025-03-03 | |||
| 2022-03-31 | $400.00K 10-Q · filed 2022-05-06 | $500.00K derived: sum of 2 quarters · filed 2024-02-29 | -$100.00K derived: sum of 3 quarters · filed 2024-02-29 | |
| 2021-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$500.00K derived: sum of 2 quarters · filed 2024-02-29 | -$500.00K 10-K · filed 2024-02-29 | |
| 2021-09-30 | -$600.00K 10-Q · filed 2021-11-05 | -$600.00K 10-Q · filed 2021-11-05 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-06 | $200.00K derived: sum of 2 quarters · filed 2023-03-01 | $900.00K derived: sum of 3 quarters · filed 2023-03-01 | $900.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $900.00K derived: sum of 2 quarters · filed 2023-03-01 | $900.00K derived: sum of 3 quarters · filed 2023-03-01 | $2.10M 10-K · filed 2023-03-01 |
| 2020-09-30 | $700.00K 10-Q · filed 2021-11-05 | $700.00K derived: sum of 2 quarters · filed 2021-11-05 | $1.90M 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.20M 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $1.20M 10-Q · filed 2021-05-10 | |||
| 2019-12-31 | $500.00K 10-K · filed 2020-03-27 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-03-27 | |||
| 2017-12-31 | $1.10M 10-K · filed 2020-03-27 | |||
| 2016-12-31 | $800.00K 10-K · filed 2019-03-01 | |||
| 2015-12-31 | $2.10M 10-K · filed 2018-03-16 | |||
| 2015-06-30 | $1.80M 10-Q · filed 2015-08-07 | $1.80M 10-Q · filed 2015-08-07 | ||
| 2012-12-31 | $6.00M 10-K · filed 2014-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |